Home / An in silico approach to identify novel and potential Akt1 (protein kinase B-alpha) inhibitors as anticancer drugs An in silico approach to identify novel and potential Akt1 (protein kinase B-alpha) inhibitors as anticancer drugs unknow ★ 5.0 · 28 reads Sign in to save this Request CodeZLIB.IO18514226 Published2022 Pages1 LanguageUnknown